OTC:CLCS | Free Cash Flow | Cell Source, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-03-31 to 2025-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-03-31-$600,391.00
2024-12-31-$748,326.00
2024-03-31-$173,852.00
2023-12-31-$722,290.00
2023-03-31-$309,613.00
2022-12-31-$723,275.00
2022-03-31-$1.03M
2021-12-31-$459,204.00
2021-03-31-$1.11M
2020-12-31-$756,612.00
2020-03-31-$618,386.00
2019-12-31-$863,340.00
2019-03-31-$405,444.00
2018-12-31-$589,187.00
2018-03-31-$709,974.00
2017-12-31-$913,577.00
2017-03-31-$334,258.00
2016-12-31-$150,328.00
2016-03-31-$803,267.00
2015-12-31-$541,996.00
2015-03-31-$693,000.00
2014-12-31-$6.06M$0.00-$6.06M
2014-03-31-$1.34M
2013-12-31$535,000.00$0.00$535,000.00
2013-03-31-$6,570.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2024-12-31-$2.68M
2023-12-31-$2.35M
2022-12-31-$3.14M
2021-12-31-$3.38M
2020-12-31-$2.77M
2019-12-31-$2.59M
2018-12-31-$2M
2017-12-31-$2.29M
2016-12-31-$1.49M
2015-12-31-$2M
2014-12-31-$3.12M$2,582.00-$3.12M
2013-12-31$894,000.00$0.00$894,000.00